Yuan Jing, Dong Rui, Liu Fei, Zhan Lijun, Liu Yu, Wei Jun, Wang Ninghua
Department of Urology, Hanyang Hospital, Wuhan University of Science and Technology, Wuhan, Hubei 430050, P.R. China.
Exp Ther Med. 2019 Apr;17(4):2457-2464. doi: 10.3892/etm.2019.7221. Epub 2019 Jan 30.
Kidney renal clear cell carcinoma (KIRC) is the most common type of renal cell carcinoma. While a number of treatments have been developed over the past few decades, the prognosis of patients with KIRC remains poor due to tumor metastasis and recurrence. Therefore, the molecular mechanisms of KIRC require to be elucidated in order to identify novel biomarkers. MicroRNAs (miRNAs/miRs) have been studied as important regulators of gene expression in a variety of cancer types. In the present study, a bioinformatics analysis of differentially expressed miRNAs in KIRC vs. normal tissues was performed based on raw miRNA expression data and patient information downloaded from the The Cancer Genome Atlas database. Furthermore, the clinical significance of differentially expressed miRNAs was evaluated, and their target genes and biological effects were further predicted. After applying the cut-off criteria of an absolute fold change of ≥2 and P<0.05, 127 differentially expressed miRNAs between KIRC and normal tissues were identified. The product of the miR-183/182/96 gene cluster, namely miR-183, miR-96 and miR-182, was revealed to be associated with multiple clinicopathological features of KIRC and to have a significant predictive and prognostic value. Subsequent functional enrichment analysis indicated that the target genes of the three miRNAs are associated with various Panther pathways, including the α-adrenergic receptor signaling pathway, metabotropic glutamate receptor group I pathway, histamine H1 receptor-mediated signaling pathway and thyrotropin-releasing hormone receptor signaling pathway. In addition, major enriched gene ontology terms in the category biological process included the intracellular signaling cascade, cellular macromolecule catabolic process and response to DNA damage stimulus. Taken together, the present study suggested that miR-183, miR-96 and miR-182 may function as potential carcinogenic factors in KIRC and may be utilized as prognostic predictors.
肾透明细胞癌(KIRC)是最常见的肾细胞癌类型。尽管在过去几十年中已开发出多种治疗方法,但由于肿瘤转移和复发,KIRC患者的预后仍然很差。因此,需要阐明KIRC的分子机制以鉴定新的生物标志物。微小RNA(miRNA/miR)已被研究为多种癌症类型中基因表达的重要调节因子。在本研究中,基于从癌症基因组图谱数据库下载的原始miRNA表达数据和患者信息,对KIRC与正常组织中差异表达的miRNA进行了生物信息学分析。此外,评估了差异表达miRNA的临床意义,并进一步预测了它们的靶基因和生物学效应。应用绝对倍数变化≥2且P<0.05的截断标准后,鉴定出KIRC与正常组织之间有127个差异表达的miRNA。miR-183/182/96基因簇的产物,即miR-183、miR-96和miR-182,被发现与KIRC的多种临床病理特征相关,并具有显著的预测和预后价值。随后的功能富集分析表明,这三种miRNA的靶基因与多种Panther通路相关,包括α-肾上腺素能受体信号通路、代谢型谷氨酸受体I组通路、组胺H1受体介导的信号通路和促甲状腺激素释放激素受体信号通路。此外,生物过程类别中主要富集的基因本体术语包括细胞内信号级联、细胞大分子分解代谢过程和对DNA损伤刺激的反应。综上所述,本研究表明miR-183、miR-96和miR-182可能在KIRC中作为潜在的致癌因素发挥作用,并可作为预后预测指标。